NCT07007234

Brief Summary

Depressive symptoms are commonly observed in the general population. Individuals with subclinical forms of depression (e.g., not meet the criteria to major depression disorder) are at increased risk of mortality than the general population which is partially explained by the higher incidence of cardiovascular diseases. Currently, the effectiveness of the frontline treatment for depression is not consensual. Further, it also may be expensive for individuals with mild to moderate depression. Sedentary behavior is an independent risk factor for cardiometabolic diseases and mental disorders. However, recent evidence suggests that not all types of sedentary behavior are equally detrimental. For instance, mentally passive sedentary behavior (e.g., watching TV) appear to be detrimental for health outcomes whereas mentally active sedentary behavior (e.g., desk-based office work) appear to offer health benefits. However, more studies are required to determine the magnitude of association between distinct types of sedentary behaviors (e.g., watching TV, listening to music, talking while sitting, sitting around and doing nothing special) with depressive symptoms as well as randomized clinical trials investigating potential benefits of interventions to replace mentally-passive sedentary behaviors with mentally active sedentary behaviors, light physical activity or moderate-to-vigorous activity in individuals with mild to moderate depression. Therefore, the aim of this proposal is to investigate the influence of mentally passive sedentary behavior (i.e., watching TV, listening to music, talking while sitting, sitting around, and doing nothing special) on depressive symptoms. This is a randomized clinical trial. Participants with mild to severe depressive symptoms will be randomly assigned (1:1) into either INTERVENTION or CONTROL group, using a computer-generated randomization code. Depressive symptoms, quality of life, physical activity, sedentary behavior, body composition, and functionality will be assessed at baseline (PRE) and 4 (POST) months after the experimental period. The INTERVENTION group will participate in a 4-month goal-setting intervention aimed to replace mentally passive sedentary behaviors with mentally active sedentary behaviors, light physical activity, or moderate-to-vigorous activity while CONTROL group will receive general instructions related to WHO guidelines for physical activity.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
84

participants targeted

Target at P50-P75 for not_applicable

Timeline
2mo left

Started Jun 2025

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress86%
Jun 2025Jul 2026

First Submitted

Initial submission to the registry

May 20, 2025

Completed
12 days until next milestone

Study Start

First participant enrolled

June 1, 2025

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 5, 2025

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Last Updated

July 25, 2025

Status Verified

July 1, 2025

Enrollment Period

1.1 years

First QC Date

May 20, 2025

Last Update Submit

July 23, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Depressive Symptoms

    The depressive symptoms will be assessed by Beck's Depressive Inventory (BDI). Score ranges from 0 to 63 points, being higher scores indicative of higher symptoms of depression.

    Baseline (Pre-intervention) and 16 weeks (Post-intervention)

Secondary Outcomes (11)

  • Anxiety Symptoms (primary outcome)

    Baseline (Pre-intervention) and 16 weeks (Post-intervention)

  • Indirect physical activity levels assessment

    Baseline (Pre-intervention) and 16 weeks (Post-intervention)

  • Objective physical activity levels assessment

    Baseline (Pre-intervention) and 16 weeks (Post-intervention)

  • Indirect sedentary behavior assessment

    Baseline (Pre-intervention) and 16 weeks (Post-intervention)

  • Objective sedentary behavior assessment

    Baseline (Pre-intervention) and 16 weeks (Post-intervention)

  • +6 more secondary outcomes

Study Arms (2)

Physical activity intervention

EXPERIMENTAL

Patients allocated to this arm will be submitted to intervention (4-month goal-setting intervention aimed to replace mentally passive sedentary behaviors with mentally active sedentary behaviors, light physical activity, or moderate-to-vigorous activity)

Behavioral: Physical activity intervention

Standard of care

EXPERIMENTAL

Patients allocated to this arm will be submitted to intervention (4 face-to-face individual sessions during 4 months, lasting \~15-30 minutes, however they will receive general instructions related to WHO guidelines for physical activity.)

Behavioral: Standard of care

Interventions

The INTERVENTION group will participate in a 4-month goal-setting intervention aimed to replace mentally passive sedentary behaviors with mentally active sedentary behaviors, light physical activity, or moderate-to-vigorous activity.

Physical activity intervention

The CONTROL group also will participate of 4 face-to-face individual sessions during the experimental period, lasting \~15-30 minutes, however they will receive general instructions related to WHO guidelines for physical activity

Standard of care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • individuals aged over 17 years;
  • mild to severe depressive symptoms.

You may not qualify if:

  • cancer in the past 5 years;
  • inability to perform the physical tests;
  • prior diagnosis of muscle degenerative disease (e.g., myopathies, amyotrophic lateral sclerosis);

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University of Santo Amaro

São Paulo, SO, 04829-300, Brazil

RECRUITING

University Santo Amaro

São Paulo, São Paulo, 04829-300, Brazil

RECRUITING

MeSH Terms

Conditions

DepressionAnxiety Disorders

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorMental Disorders

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD.

Study Record Dates

First Submitted

May 20, 2025

First Posted

June 5, 2025

Study Start

June 1, 2025

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

July 1, 2026

Last Updated

July 25, 2025

Record last verified: 2025-07

Locations